Resources

The ninth Hepatitis C in the UK report follows the WHO Global Health Sector Strategy (GHSS) on Viral Hepatitis 2016-2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the GHSS goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.

On 9th May 2017, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Cambridge. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Cambridge and the wider east of England region.

This report by Public Health England has been produced to support monitoring of the recently agreed Global Health Sector Strategy on Viral Hepatitis goals, including the elimination of hepatitis C as a major public health threat by 2030. The report summarises the impact of action plans in England to drive down mortality from hepatitis C, reduce the number of new infections, and outlines the actions required to make further progress.

These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.